CM
RVMD icon

Caption Management’s Revolution Medicines RVMD Stock Holding History

Caption Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-314,836
Closed -$20.6M – 2003
2025
Q3 		$14.7M Buy
+314,836
New +$12.3M 0.11% 193
2025
Q1 		– Sell
-72,795
Closed -$3.18M – 1965
2024
Q4 		$3.18M Buy
+72,795
New +$3.67M 0.03% 532
2024
Q2 		– Sell
-14,000
Closed -$451K – 1456
2024
Q1 		$451K Buy
+14,000
New +$415K 0.01% 889
2023
Q4 		– Sell
-4,601
Closed -$111K – 1624
2023
Q3 		$127K Buy
+4,601
New +$136K ﹤0.01% 1135

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Caption Management's RVMD Position: Q4 2025 in Review

Caption Management sold out of Revolution Medicines (RVMD) in Q4 2025, closing a stake of 314,836 shares — an estimated $20.6M sold.

Caption Management first reported a position in RVMD in Q3 2023 and held it in 4 quarters. The position peaked at $14.7M in Q3 2025. 386 funds tracked by Wall St. Rank hold RVMD as of Q4 2025.

  • Caption Management reported no remaining Revolution Medicines position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 314,836 Revolution Medicines shares in Q4 2025, an estimated $20.6M.
  • Caption Management first reported a position in Revolution Medicines in Q3 2023 and held it in 4 quarters.
  • Caption Management's Revolution Medicines position peaked at $14.7M in Q3 2025.
  • 386 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.